Target intelligence / Profile preview

Alpha-like protein family (Alp family) (Alp family)

Target
Alp family
Molecular classification
Bacterial surface protein, Adhesin, Antigen, Other
01

Overview

The Alpha-like protein (Alp) family is a group of surface-anchored proteins found in Streptococcus agalactiae (Group B Streptococcus, GBS), which is a leading cause of neonatal sepsis and meningitis (Lindahl et al., 2005). This family includes the Alpha C protein, Rib, and Alp1 through Alp4, all of which share a similar structural organization characterized by a conserved N-terminal signal sequence, a large repeat region, and a C-terminal cell wall anchoring motif (Maeland et al., 2015). These proteins play critical roles in bacterial pathogenesis by mediating adhesion to host epithelial cells and facilitating invasion, as well as contributing to immune evasion by interfering with host complement deposition (Bolduc et al., 2002). Because these proteins are highly immunogenic and expressed across most GBS clinical isolates, they are primary targets for the development of protein-based maternal vaccines (Minervax, 2023). Current therapeutic strategies focus on using recombinant N-terminal domains of these proteins to elicit opsonophagocytic antibodies that provide passive immunity to newborns (Fischer et al., 2021). The diversity within the Alp family necessitates multivalent vaccine approaches to ensure broad protection against various GBS strains (Creti et al., 2004).

Other names
Alp proteinsAlpha-antigen familyGroup B Streptococcus surface proteinsAlpha-C-like proteinsBca-like proteins
02

Mechanism of action

Induction of opsonophagocytic antibodies that facilitate bacterial clearance by the host immune system (Maeland et al., 2015).

03

Biological functions

Bacterial adhesionHost cell invasionImmune evasionBiofilm formation
04

Disease associations

Infection
05

Safety considerations

Strain-specific coveragePotential for antigenic variationImmunological interference in multivalent formulations
06

Interacting drugs

GBS-NN

1 more in the full profile.

07

Biomarkers

Anti-Alp IgG titersOpsonophagocytic activity (OPA)

Beyond the preview

Go deeper on Alpha-like protein family (Alp family) (Alp family).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-like protein family (Alp family) (Alp family).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call